Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

S-5920 effective in rat model of acute pancreatitis

Dec. 19, 1997

LeukoSite, Genentech collaborate on IBD therapeutic

Dec. 19, 1997

SciClone acquires rights to Zadaxin

Dec. 19, 1997

Z-103 as effective as sulfasalazine in rat model of colitis

Dec. 17, 1997

Toa Eiyo discovers new anti-H. pylori agents

Dec. 17, 1997

Dainippon discloses new H+/K+-ATPase inhibitors

Dec. 17, 1997

Astra Merck and P&G to develop OTC formulation of Prilosec for heartburn

Dec. 17, 1997

Sagami discovers lead for potent and selective anti-H. pylori agents

Dec. 16, 1997

ViroPharma develops agents for HCV infection

Dec. 16, 1997

FDA approves URSO for PBC

Dec. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.